0001734768-22-000001.txt : 20220103 0001734768-22-000001.hdr.sgml : 20220103 20220103143750 ACCESSION NUMBER: 0001734768-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220103 DATE AS OF CHANGE: 20220103 EFFECTIVENESS DATE: 20220103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMV Inc. CENTRAL INDEX KEY: 0001734768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-427645 FILM NUMBER: 22501695 BUSINESS ADDRESS: STREET 1: 130 EILEEN STUBBS AVE. STREET 2: SUITE 19 CITY: DARTMOUTH STATE: A5 ZIP: B3B 2C4 BUSINESS PHONE: 9024921819 MAIL ADDRESS: STREET 1: 130 EILEEN STUBBS AVE. STREET 2: SUITE 19 CITY: DARTMOUTH STATE: A5 ZIP: B3B 2C4 FORMER COMPANY: FORMER CONFORMED NAME: Immunovaccine Inc. DATE OF NAME CHANGE: 20180316 D 1 primary_doc.xml X0708 D LIVE 0001734768 IMV Inc. 130 EILEEN STUBBS AVE. SUITE 19 DARTMOUTH A5 NOVA SCOTIA, CANADA B3B 2C4 9024921819 CANADA (FEDERAL LEVEL) Rhino Resources Inc. Immunovaccine Inc. Corporation true Andrew Hall 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Executive Officer Jeremy Graff 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Executive Officer Pierre Labbe 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Executive Officer Andrew Sheldon 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Director Michael Bailey 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Director Julia Gregory 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Director Michael Kalos 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Director Kyle Kuvalanka 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Director Shermaine Tilley 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Director Markus Warmuth 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Director Biotechnology No Revenues 06b false 2021-12-17 true true true true true Each warrant is exercisable for either 56,818 or 113,636 common shares at an exercise price of $1.32 per common share until December 17, 2031. false 0 749998 0 749998 The additional $749,998.00 may be received upon the exercise of the warrants sold inside or outside the U.S. false 2 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false IMV Inc. Pierre Labbe Pierre Labbe CFO 2022-01-03